Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite?
Kiykim, Ayca; Mumcu, Gonca; Ogulur, Ismail; Karakoc-Aydiner, Elif; Direskeneli, Haner; Baris, Safa; Cagan, Hasret; Ozen, Ahmet.
Int Arch Allergy Immunol
; 174(1): 52-56, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28950285
Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
[Long-term clinical effect and safety observation of sublingual dermatophagoides farinae drop in preschool and school-age children with allergic rhinitis].
[Efficacy and safety of specific sublingual immunotherapy in children with allergic asthma and rhinitis].
Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
Variation in allergen content in sublingual allergen immunotherapy with house dust mites.
Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.
Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial.
[Analysis of the efficacy of specific immunotherapy of allergic rhinitis after withdrawal of dust mites drops in about one year].
Tablet-based sublingual immunotherapy for respiratory allergy.